SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended					9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
REVENUE	$ 3,575,966			$ 3,091,012		$ 10,117,296	$ 7,264,554
COST OF REVENUE	(2,887,867)			(2,568,790)		(8,379,025)	(5,927,735)
GROSS PROFIT	688,099			522,222		1,738,271	1,336,819
OTHER INCOME	46,848			9,089		159,764	779,458
PROFIT BEFORE TAX	370,491			234,950		845,777	1,270,100
Tax expense	(75,169)			(492)		(183,449)	(1,839)
Net profit	$ 295,322	$ 28,262	$ 338,744	$ 234,458	$ 1,069,644	662,328	1,268,261
TOTAL [Member]
REVENUE						10,117,296	7,264,554
COST OF REVENUE						(8,379,025)	(5,927,735)
GROSS PROFIT						1,738,271	1,336,819
OTHER INCOME						159,764	779,458
General and administrative						(1,043,271)	(839,415)
FINANCE COSTS						(8,987)	(6,762)
PROFIT BEFORE TAX						845,777	1,270,100
Tax expense						(183,449)	(1,839)
Net profit						662,328	1,268,261
BioNexus Malaysia [Member]
REVENUE						1,504,064	30,012
COST OF REVENUE						(1,108,817)	(45,561)
GROSS PROFIT						395,247	(15,549)
OTHER INCOME						5,335	10,540
General and administrative						(64,255)	(67,852)
FINANCE COSTS						(3,265)	(1,480)
PROFIT BEFORE TAX						333,062	(74,341)
Tax expense						(38,068)	(1,839)
Net profit						294,994	(76,180)
Chemrex [Member]
REVENUE						8,613,232	7,234,542
COST OF REVENUE						(7,270,208)	(5,882,174)
GROSS PROFIT						1,343,024	1,352,368
OTHER INCOME						154,429	768,910
General and administrative						(843,620)	(673,211)
FINANCE COSTS						(5,722)	(5,282)
PROFIT BEFORE TAX						648,111	1,442,785
Tax expense						(145,381)	0
Net profit						502,370	1,442,785
BGLC [Member]
REVENUE						0	0
COST OF REVENUE						0	0
GROSS PROFIT						0	0
OTHER INCOME						0	8
General and administrative						(135,396)	(98,352)
FINANCE COSTS						0	0
PROFIT BEFORE TAX						(135,396)	(98,344)
Tax expense						0	0
Net profit						$ (135,396)	$ (98,344)